Credit Suisse Downgrades Pharmacyclics Amid Takeover Rumors

By: via Benzinga
Credit Suisse on Thursday issued a report on Pharmacyclics, Inc.(NASDAQ: PCYC) a day after the company soared 17 percent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.